Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

NCT02654158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2017-05-22

No results posted yet for this study

Summary

Phase IV trial,Single-arm, multi-centre clinical trial to assess the efficacy and safety of Fuganlin Oral Liquid in children with acute upper respiratory infection

Conditions

  • Acute Upper Respiratory Infection

Interventions

DRUG

Low-dose of Fuganlin Oral Liquid

less than 1 years old: 5mL each time and three times a day 1\~3 years old: 10mL each time and three times a day 4\~6 years old: 10mL each time and four times a day 7\~12 years old: 10mL each time and five times a day

DRUG

High-dose of Fuganlin Oral Liquid

less than 1 years old: 10mL each time and three times a day 1\~3 years old: 20mL each time and three times a day 4\~6 years old: 20mL each time and four times a day 7\~12 years old: 20mL each time and five times a day

Sponsors & Collaborators

  • Guangzhou Yipinhong Pharmaceutical CO.,LTD

    lead INDUSTRY

Principal Investigators

  • Li xinmin, PhD · The First Affiliated Hospital of Tianjing University of Traditional Chinese Medicine

  • Chang ke, MD · Chengdu University of Traditional Chinese Medicine

  • Meng qingping, MD · Zhengzhou Children's Hospital

  • Tao lei, MD · Huanggang Maternal and Child Health Hospital

  • Ding ying, MD · Children's Hospital of The First Affiliated Hospital of Henan College of Traditional Chinese Medicine

  • Xiang xixiong, PhD · Hubei Hospital of Traditional Chinese Medicine

  • Cheng ji, MD · Second Affiliated Hospital of Wenzhou Medical University

  • Ying yong, MD · Affiliated Shanghai Children's Medical Center of Shanghai Jiaotong University School of medicine

  • Liu changshan, MD · Tianjin Medical University Second Hospital

  • Mou qinghui, MD · Jinan children's hospital

  • Liu yulin, MD · BoAi Hospital of Zhongshan

  • Wang lisheng, PhD · Shenzhen Children's Hospital

  • Zhao deyu, PhD · Affiliated Nanjing Children's Hospital of Nanjing Medical University

  • Du yonggang, MD · Changzhi People's Hospital

  • Su baoling, MD · Affiliated Heji Hospital of Changzhi Medical College

  • Qing yanhong, MD · Affiliated Hospital of Shanxi College of Traditional Chinese medicine

  • Cheng zhimin, PhD · Affiliated Children's Hospital of Zhejiang University School of Medicine

  • Lin yan, MD · Chengdu Women and Children's Hospital

  • Xu youjia, MD · Guangdong Provincial Hospital of Traditional Chinese Medicine

  • Zhang mingying, MD · Beijing Shunyi Hospital of China Medical University

Eligibility

Min Age
1 Year
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654158 on ClinicalTrials.gov